Andrew Chi, MD, PhD at NYU Langone Medical Center Explains How NYU is 1st Actively Enrolling Site for ONC201 in Adults With Recurrent H3 K27M High-grade Glioma Trial. Clinical Trial: ONC201 in Adults With Recurrent H3 K27M High-grade Glioma.
NYU is 1st Actively Enrolling Site for ONC201 in Adults With Recurrent H3 K27M High-grade Glioma Trial
